SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
+27.15%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$994K
AUM Growth
+$994K
Cap. Flow
-$4.79M
Cap. Flow %
-481.68%
Top 10 Hldgs %
86.65%
Holding
46
New
10
Increased
4
Reduced
16
Closed
3

Top Buys

1
JYAC
Jiya Acquisition Corp. Class A Common Stock
JYAC
$507K
2
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$50.3K
3
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$7.79K
4
KRON
Kronos Bio
KRON
$4.97K
5
BLSA
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$3.34K

Top Sells

1
AIMT
Aimmune Therapeutics, Inc.
AIMT
$2M
2
SPRO icon
Spero Therapeutics
SPRO
$1.79M
3
UROV
Urovant Sciences Ltd.
UROV
$1.47M
4
COGT icon
Cogent Biosciences
COGT
$57.2K
5
CVAC icon
CureVac
CVAC
$22.3K

Sector Composition

1 Financials 51.32%
2 Healthcare 47.85%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
JYAC
1
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$507K 50.99% +5,223 New +$507K
NKTX icon
2
Nkarta
NKTX
$151M
$125K 12.58% 2,034,703 – –
KDNY
3
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$50.3K 5.05% +3,168,388 New +$50.3K
FMTX
4
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$49.5K 4.98% 1,418,529 -73,634 -5% -$2.57K
STRO icon
5
Sutro Biopharma
STRO
$72.7M
$36.4K 3.66% 1,675,579 – –
SYRS
6
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$21.8K 2.2% 2,189,199 +781,250 +55% +$7.79K
ALLK
7
DELISTED
Allakos
ALLK
$20.5K 2.06% 146,259 -46,075 -24% -$6.45K
SWTX
8
DELISTED
SpringWorks Therapeutics
SWTX
$19K 1.91% 262,572 -135,445 -34% -$9.82K
ISEE
9
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$16.4K 1.65% 2,372,476 -998,002 -30% -$6.9K
ODT
10
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$15.7K 1.57% 815,421 – –
ICPT
11
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$9.97K 1% 403,688 – –
ACRS icon
12
Aclaris Therapeutics
ACRS
$209M
$8.82K 0.89% 1,362,612 -790,653 -37% -$5.12K
VRNA
13
Verona Pharma
VRNA
$9.16B
$7.78K 0.78% 1,111,112 – –
CVAC icon
14
CureVac
CVAC
$1.21B
$7.73K 0.78% 95,318 -275,067 -74% -$22.3K
BCEL
15
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$7.67K 0.77% 474,943 -142,617 -23% -$2.3K
SYRE icon
16
Spyre Therapeutics
SYRE
$996M
$6.96K 0.7% 883,720 – –
COGT icon
17
Cogent Biosciences
COGT
$1.69B
$6.61K 0.67% 588,961 -5,092,857 -90% -$57.2K
RYTM icon
18
Rhythm Pharmaceuticals
RYTM
$6.85B
$5.98K 0.6% 201,046 -33,800 -14% -$1.01K
EQ icon
19
Equillium
EQ
$62.2M
$5.75K 0.58% 1,074,285 – –
TNGX icon
20
Tango Therapeutics
TNGX
$747M
$5.72K 0.58% 500,000 – –
PANA.U
21
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$5.1K 0.51% 400,000 – –
ALPN
22
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$5.03K 0.51% 399,190 -95,000 -19% -$1.2K
KRON
23
DELISTED
Kronos Bio
KRON
$4.97K 0.5% +166,250 New +$4.97K
KALA icon
24
KALA BIO
KALA
$78.8M
$4.08K 0.41% 601,162 +150,000 +33% +$1.02K
ALBO
25
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
$3.75K 0.38% 100,000 – –
1
2